Cargando…
Comparison of Dexamethasone 4mg vs 8mg Doses in Total Joint Arthroplasty Patients: A Retrospective Analysis
Introduction Dexamethasone is commonly administered intraoperatively to control postoperative nausea and vomiting (PONV) and pain. There is limited evidence of the ideal dosage of dexamethasone during surgery. Dexamethasone administration may increase blood glucose levels, posing unique challenges i...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540179/ https://www.ncbi.nlm.nih.gov/pubmed/33047085 http://dx.doi.org/10.7759/cureus.10295 |
_version_ | 1783591152545431552 |
---|---|
author | Arumugam, Sivasenthil Woolley, Katherine Smith, Ryan A Vellanky, Smitha Cremins, Michael S Dulipsingh, Latha |
author_facet | Arumugam, Sivasenthil Woolley, Katherine Smith, Ryan A Vellanky, Smitha Cremins, Michael S Dulipsingh, Latha |
author_sort | Arumugam, Sivasenthil |
collection | PubMed |
description | Introduction Dexamethasone is commonly administered intraoperatively to control postoperative nausea and vomiting (PONV) and pain. There is limited evidence of the ideal dosage of dexamethasone during surgery. Dexamethasone administration may increase blood glucose levels, posing unique challenges in maintaining acceptable blood glucose levels in patients with diabetes. Objective Compare two doses of dexamethasone (4mg and 8mg) for outcomes in patients undergoing hip and knee arthroplasty. Methods Medical records of 3,194 patients having undergone total hip arthroplasty (THA) and total knee arthroplasty (TKA) between January 1, 2016 and December 31, 2017 who were administered dexamethasone were reviewed. The eligible population included male and female patients aged 18-89, who underwent elective hip and knee replacement surgery and were administered dexamethasone intraoperatively. Demographics, clinical variables, and preoperative diabetic status were recorded. Primary outcomes included: blood glucose levels, incidence of PONV, post-anesthesia care unit (PACU) time, and length of stay (LOS). Postoperative complications such as periprosthetic joint injection and urinary tract infections (UTI) were also examined within 90 days of surgery. The 30-day readmissions rate was also collected for analysis. Results There was no PONV in the entire patient population. There were no significant differences between 4mg and 8mg dexamethasone in patients with or without diabetes, for preop to postop blood glucose difference, surgical timing, and post-operative complications. Conclusion Dexamethasone in both 4mg and 8mg dose was effective in PONV prophylaxis. The effects of 4mg and 8mg dexamethasone were the same in individuals with and without diabetes and the increases in blood glucose were not significantly different. Dexamethasone should not be withheld, as its benefits seem to outweigh the risks even in patients with diabetes. |
format | Online Article Text |
id | pubmed-7540179 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-75401792020-10-11 Comparison of Dexamethasone 4mg vs 8mg Doses in Total Joint Arthroplasty Patients: A Retrospective Analysis Arumugam, Sivasenthil Woolley, Katherine Smith, Ryan A Vellanky, Smitha Cremins, Michael S Dulipsingh, Latha Cureus Anesthesiology Introduction Dexamethasone is commonly administered intraoperatively to control postoperative nausea and vomiting (PONV) and pain. There is limited evidence of the ideal dosage of dexamethasone during surgery. Dexamethasone administration may increase blood glucose levels, posing unique challenges in maintaining acceptable blood glucose levels in patients with diabetes. Objective Compare two doses of dexamethasone (4mg and 8mg) for outcomes in patients undergoing hip and knee arthroplasty. Methods Medical records of 3,194 patients having undergone total hip arthroplasty (THA) and total knee arthroplasty (TKA) between January 1, 2016 and December 31, 2017 who were administered dexamethasone were reviewed. The eligible population included male and female patients aged 18-89, who underwent elective hip and knee replacement surgery and were administered dexamethasone intraoperatively. Demographics, clinical variables, and preoperative diabetic status were recorded. Primary outcomes included: blood glucose levels, incidence of PONV, post-anesthesia care unit (PACU) time, and length of stay (LOS). Postoperative complications such as periprosthetic joint injection and urinary tract infections (UTI) were also examined within 90 days of surgery. The 30-day readmissions rate was also collected for analysis. Results There was no PONV in the entire patient population. There were no significant differences between 4mg and 8mg dexamethasone in patients with or without diabetes, for preop to postop blood glucose difference, surgical timing, and post-operative complications. Conclusion Dexamethasone in both 4mg and 8mg dose was effective in PONV prophylaxis. The effects of 4mg and 8mg dexamethasone were the same in individuals with and without diabetes and the increases in blood glucose were not significantly different. Dexamethasone should not be withheld, as its benefits seem to outweigh the risks even in patients with diabetes. Cureus 2020-09-07 /pmc/articles/PMC7540179/ /pubmed/33047085 http://dx.doi.org/10.7759/cureus.10295 Text en Copyright © 2020, Arumugam et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Anesthesiology Arumugam, Sivasenthil Woolley, Katherine Smith, Ryan A Vellanky, Smitha Cremins, Michael S Dulipsingh, Latha Comparison of Dexamethasone 4mg vs 8mg Doses in Total Joint Arthroplasty Patients: A Retrospective Analysis |
title | Comparison of Dexamethasone 4mg vs 8mg Doses in Total Joint Arthroplasty Patients: A Retrospective Analysis |
title_full | Comparison of Dexamethasone 4mg vs 8mg Doses in Total Joint Arthroplasty Patients: A Retrospective Analysis |
title_fullStr | Comparison of Dexamethasone 4mg vs 8mg Doses in Total Joint Arthroplasty Patients: A Retrospective Analysis |
title_full_unstemmed | Comparison of Dexamethasone 4mg vs 8mg Doses in Total Joint Arthroplasty Patients: A Retrospective Analysis |
title_short | Comparison of Dexamethasone 4mg vs 8mg Doses in Total Joint Arthroplasty Patients: A Retrospective Analysis |
title_sort | comparison of dexamethasone 4mg vs 8mg doses in total joint arthroplasty patients: a retrospective analysis |
topic | Anesthesiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540179/ https://www.ncbi.nlm.nih.gov/pubmed/33047085 http://dx.doi.org/10.7759/cureus.10295 |
work_keys_str_mv | AT arumugamsivasenthil comparisonofdexamethasone4mgvs8mgdosesintotaljointarthroplastypatientsaretrospectiveanalysis AT woolleykatherine comparisonofdexamethasone4mgvs8mgdosesintotaljointarthroplastypatientsaretrospectiveanalysis AT smithryana comparisonofdexamethasone4mgvs8mgdosesintotaljointarthroplastypatientsaretrospectiveanalysis AT vellankysmitha comparisonofdexamethasone4mgvs8mgdosesintotaljointarthroplastypatientsaretrospectiveanalysis AT creminsmichaels comparisonofdexamethasone4mgvs8mgdosesintotaljointarthroplastypatientsaretrospectiveanalysis AT dulipsinghlatha comparisonofdexamethasone4mgvs8mgdosesintotaljointarthroplastypatientsaretrospectiveanalysis |